Mr. Slipkovich’s compensation included a base salary of $633,333, an increase of more than $100,000 from 2011. He also received $300,000 in bonuses and incentives, which were based on EBITDA goals and an evaluation. Overall, his compensation was almost 75 percent higher year-over-year.
Capella CFO Denise Warren’s compensation increased 30 percent to $645,174. Her base salary rose to $441,692, while non-equity incentives reached $200,000.
Capella, a for-profit hospital that owns 13 acute-care hospitals and is primarily backed by Chicago-based private equity firm GTCR, lost $14.1 million in FY 2012, the second straight year it lost at least $14 million. However, total revenue increased more than 9.3 percent to $747.8 million.
More Articles on Hospital Executive Compensation:
Tenet CEO Trevor Fetter’s Compensation Rises 5% to $11.2M
Universal Health Services Releases Details on Exec Bonuses for 2013
How Can Hospitals Battle Community Perception of Executive Pay?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
